Sonoma Pharmaceuticals Inc SNOA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $1.07
- Day Range
- $1.08–1.15
- 52-Week Range
- $0.85–3.95
- Bid/Ask
- $1.11 / $1.12
- Shares Outstanding
- 4.79M
- Market Cap
- $5.32M
- Volume/Avg
- 44,525 / 103,413
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.09
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 260
- Website
- https://www.sonomapharma.com
Valuation
Metric | SNOA |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.81 |
Price/Sales | 0.09 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | SNOA |
|---|---|
Quick Ratio | 1.56 |
Current Ratio | 2.99 |
Interest Coverage | — |
Quick Ratio
SNOA
Profitability
Metric | SNOA |
|---|---|
Return on Assets (Normalized) | −13.71% |
Return on Equity (Normalized) | −48.48% |
Return on Invested Capital (Normalized) | −41.64% |
Return on Assets
SNOA
Drug Manufacturers - Specialty & Generic Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Merck KGaA ADR MKKGY | LOCK|lQ%!cFYw | LOCK|L^!@ | $73B | |||
| Teva Pharmaceutical Industries Ltd TEVA | LOCK|bw#>zFJ | LOCK|k>!^ | $48B | |||
| Haleon PLC ADR HLN | LOCK|KD$C<?> | LOCK|<tm | $40B | |||
| Zoetis Inc Class A ZTS | LOCK|!clMJj$ | LOCK|V#n | $32B | |||
| Viatris Inc VTRS | LOCK|r<P>mp | LOCK|$@ | $23B | |||
| Elanco Animal Health Inc ELAN | LOCK|@<# | LOCK|$Q | $13B | |||
| Dr Reddy's Laboratories Ltd ADR RDY | LOCK|^#sgsX | LOCK|z$K | $12B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A HIMS | LOCK|Jp#nqCL | LOCK|ZNx | $6B | |||
| Perrigo Co PLC PRGO | LOCK|r@&fVGC | LOCK|&>% | $2B | |||
| Prestige Consumer Healthcare Inc PBH | LOCK|>^^s>P | LOCK|qM#y? | $2B |
United States